Person

Carmen Bozic

EVP and CMO, Vertex Pharmaceuticals

Current S&P 500 boards
0
Current roles
1
Open-market buys
$0
Open-market sales
$30.0M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

None on record since 2016.

Sits alongside

People who currently share a board or management team with this person.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Jun 26, 2026VRTXSale596$482.50$288K
Jun 18, 2026VRTXSale1,020$462.17$471K
Jun 15, 2026VRTXSale4,062$450.00$1.8M
Jun 5, 2026VRTXSale1,745$450.00$785K
May 29, 2026VRTXSale1,974$450.00$888K
May 15, 2026VRTXSale1,354$453.45$614K
May 12, 2026VRTXSale6,988$450.00$3.1M
Mar 27, 2026VRTXSale2,329$450.95$1.1M
Mar 13, 2026VRTXSale2,329$481.79$1.1M
Feb 27, 2026VRTXSale2,329$480.31$1.1M
Aug 7, 2024VRTXSale2,280$476.75$1.1M
Jul 24, 2024VRTXSale2,280$488.46$1.1M
Jul 10, 2024VRTXSale2,280$487.34$1.1M
Jun 26, 2024VRTXSale2,280$471.72$1.1M
Jun 12, 2024VRTXSale2,280$478.00$1.1M
May 29, 2024VRTXSale2,280$445.56$1.0M
Nov 14, 2023VRTXSale5,650$380.82$2.2M
Oct 31, 2023VRTXSale5,651$355.92$2.0M
Oct 17, 2023VRTXSale5,651$373.25$2.1M
Oct 3, 2023VRTXSale5,651$345.28$2.0M
Sep 19, 2023VRTXSale5,651$351.00$2.0M
Sep 5, 2023VRTXSale5,651$352.66$2.0M

SEC reporting-owner ID (CIK) 1790029 · all filings on EDGAR

Carmen Bozic (VRTX) | USBoard